Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Sterilization Services Market
5.1. COVID-19 Landscape: U.S. Sterilization Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. Sterilization Services Market, By Technique
8.1. U.S. Sterilization Services Market, by Technique, 2022-2030
8.1.1. Steam
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. EtO
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. E-beam radiation
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Gamma radiation
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global U.S. Sterilization Services Market, By Type
9.1. U.S. Sterilization Services Market, by Type e, 2022-2030
9.1.1. Contract services
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Validation services
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global U.S. Sterilization Services Market, By Delivery Mode
10.1. U.S. Sterilization Services Market, by Delivery Mode, 2022-2030
10.1.1. Onsite
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Offsite
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global U.S. Sterilization Services Market, By End-use
11.1. U.S. Sterilization Services Market, by End-use, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Medical device companies
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Clinical laboratories
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global U.S. Sterilization Services Market, Regional Estimates and Trend Forecast
12.1. U.S.
12.1.1. Market Revenue and Forecast, by Technique (2017-2030)
12.1.2. Market Revenue and Forecast, by Type (2017-2030)
12.1.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
12.1.4. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 13. Company Profiles
13.1. Steris PLC
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. 3M
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Advanced Sterilization Products Services
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cantel
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. J&J
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Stryker
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. E-beam
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cretex
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sotera Health
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms